- Tipo NewsBANDO
- FonteFunding & Tenders Portal
- Del
Il 2 luglio 2019 la Commissione europea ha ufficialmente aggiornato il Work Programme 2018-2020 Health, demographic change and wellbeing di Horizon 2020 con informazioni relativamente al bando Better Health and care, economic growth and sustainable health systems.
Di seguito i topic contenuti nella call:
Data apertura: 4 luglio 2019
- SC1-BHC-08-2020 (RIA): New interventions for Non-Communicable Diseases
- SC1-BHC-24-2020 (RIA): Healthcare interventions for the management of the elderly multimorbid patient
- SC1-BHC-29-2020 (RIA): Innovative actions for improving urban health and wellbeing - addressing environment, climate and socioeconomic factors
- SC1-DTH-13-2020 (RIA): Implementation research for scaling up and transfer of innovative solutions involving digital tools for people-centred care
Data chiusura First stage: 26 settembre 2019 (prorogata rispetto la scadenza iniziale del 24 settembre 2019); data chiusura Second stage: 4 giugno 2020 (posticipata causa COVID-19 rispetto alla scadenza iniziale prevista per il 7 aprile 2020)
- SC1-BHC-37-2020 (RIA-LS): Towards the new generation of clinical trials – trials methodology research
- SC1-BHC-06-2020 (RIA): Digital diagnostics – developing tools for supporting clinical decisions by integrating various diagnostic data
- SC1-BHC-11-2020 (RIA): Advancing the safety assessment of chemicals without the use of animal testing
- SC1-BHC-17-2020 (RIA): Global Alliance for Chronic Diseases (GACD) - Prevention and/or early diagnosis of cancer
- SC1-BHC-20A-2020 (PCP): Pre-commercial procurement (PCP) for integrated care solutions
- SC1-BHC-20B-2020 (PPI): Public procurement of innovative solutions (PPI) for diagnostics for infectious diseases
- SC1-BHC-33-2020 (RIA): Addressing low vaccine uptake
- SC1-BHC-34-2020 (RIA): New approaches for clinical management and prevention of resistant bacterial infections in high prevalence settings
- SC1-BHC-35-2020 (RIA): Creation of a European wide sustainable network for harmonised large-scale clinical research studies for infectious diseases
- SC1-BHC-36-2020 (RIA): Micro- and nano-plastics in our environment: Understanding exposures and impacts on human health
- SC1-DTH-12-2020 (RIA): Use of Real-World Data to advance research on the management of complex chronic conditions
- SC1-HCC-10-2020 (CSA): Towards a Health research and innovation Cloud: Capitalising on data sharing initiatives in health research
- SC1-HCO-01-2018-2019-2020 (CSA): Actions in support of the International Consortium for Personalised Medicine
- SC1-HCO-03-2020 (CSA): Bridging the divide in health research and innovation – boosting return on investment
- SC1-HCO-07-2020 (ERA-NETCofund): ERA-NET to support the Joint Programming Initiative on Antimicrobial resistance (JPIAMR)
- SC1-HCO-14-2020 (ERA-NETCofund): ERA-NET: Sustained collaboration of national and regional programmes in cancer research
- SC1-HCO-16-2020 (ERA-NETCofund): ERA-NET: Sustained collaboration of national and regional programmes in research on brain-related diseases and disorders of the nervous system
- SC1-HCO-17-2020 (CSA): Coordinating and supporting research on the human microbiome in Europe and beyond
- SC1-HCO-18-2020 (CSA): Developing methodological approaches for improved clinical investigation and evaluation of high-risk medical devices
- SC1-HCO-19-2020 (CSA): Reliable and accessible information on cell and gene-based therapies
- SC1-HCO-20-2020 (CSA): Coordination of clinical research activities of the European Reference Networks
Data chiusura: 4 giugno 2020 (posticipata causa COVID-19 rispetto alla scadenza iniziale prevista per il 15 aprile 2020)
---
TOPIC CHIUSI:
- SC1-BHC-01-2019: Understanding causative mechanisms in co- and multimorbidities combining mental and non-mental disorders
- SC1-BHC-02-2019: Systems approaches for the discovery of combinatorial therapies for complex disorders
- SC1-BHC-14-2019: Stratified host-directed approaches to improve prevention, treatment and/or cure of infectious diseases
- SC1-BHC-19-2019: Implementation research for maternal and child health
- SC1-BHC-22-2019: Mental health in the workplace
- SC1-BHC-25-2019: Demonstration pilots for implementation of personalised medicine in healthcare
- SC1-BHC-30-2019: Towards risk-based screening strategies for non-communicable diseases
- SC1-BHC-07-2019: Regenerative medicine: from new insights to new applications
- SC1-BHC-10-2019: Innovation Procurement: Next generation sequencing (NGS) for routine diagnosis
- SC1-BHC-13-2019: Mining big data for early detection of infectious disease threats driven by climate change and other factors
- SC1-BHC-28-2019: The Human Exposome Project: a toolbox for assessing and addressing the impact of environment on health
- SC1-HCO-01-2018-2019-2020: Actions in support of the International Consortium for Personalised Medicine
- SC1-BHC-31-2019: Pilot actions to build the foundations of a human cell atlas
- SC1-BHC-32-2019: Towards a next generation influenza vaccine to protect citizens worldwide – an EU-India collaboration
- SC1-HCO-15-2019: Support for the functioning of the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R)
- SC1-BHC-03-2018: Exploiting research outcomes and application potential of the human microbiome for personalised prediction, prevention and treatment of disease
- SC1-BHC-04-2018: Rare Disease European Joint Programme Cofund
- SC1-BHC-05-2018: International flagship collaboration with Canada for human data storage, integration and sharing to enable personalised medicine approaches
- SC1-BHC-09-2018: Innovation platforms for advanced therapies of the future
- SC1-BHC-16-2018: Global Alliance for Chronic Diseases (GACD) - Scaling-up of evidence-based health interventions at population level for the prevention and management of hypertension and/or diabetes
- SC1-BHC-18-2018: Translational collaborative cancer research between Europe and the Community of Latin American and Caribbean States (CELAC)
- SC1-BHC-21-2018: Research on HIV, tuberculosis (TB) and/or hepatitis C (HCV) in patients with mono-, co-infections and/or comorbidities in the context of fostering collaboration with the Russian Federation
- SC1-BHC-23-2018: Novel patient-centred approaches for survivorship, palliation and/or end-of-life care
- SC1-BHC-26-2018: HTA research to support evidence-based healthcare
- SC1-BHC-27-2018: New testing and screening methods to identify endocrine disrupting chemicals
- SC1-HCO-01-2018-2019-2020: Actions in support of the International Consortium for Personalised Medicine
- SC1-HCO-02-2018: Data integration and data-driven in-silico models for enabling personalised medicine - a European standardization framework
- SC1-HCO-04-2018: ERA-NET to support the Joint Programming in Neurodegenerative Diseases strategic plan (JPND)
- SC1-HCO-05-2018: Strengthening regulatory sciences and supporting regulatory scientific advice
- SC1-HCO-06-2018: Establishment of an International Network of Social Sciences Research Centres to help address governance and other challenges in the preparedness for and the response to infectious threats
- SC1-HCO-08-2018: Creation of a European wide sustainable clinical research network for infectious diseases
- SC1-HCO-09-2018: Building international efforts on population and patient cohorts
- SC1-HCO-10-2018: Coordinating European brain research and developing global initiatives
- SC1-HCO-11-2018: Strategic collaboration in health research and innovation between EU and China
- SC1-HCO-12-2018: Innovation in healthcare - a CSA towards using pre-commercial procurement and public procurement of innovative solutions in healthcare systems
- SC1-HCO-13-2018: Setting the priorities for a European environment, climate and health research agenda
- SC1-BHC-15-2018: New anti-infective agents for prevention and/or treatment of neglected infectious diseases (NID)
445 milioni per il 2018, 565 per il 2019, 498 milioni per il 2020